These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 24396289

  • 1. Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-positive cervical cytology.
    Lee SJ, Lee AW, Kang CS, Park JS, Park DC, Ki EY, Lee KH, Yoon JH, Hur SY, Kim TJ.
    Int J Med Sci; 2014; 11(1):80-6. PubMed ID: 24396289
    [Abstract] [Full Text] [Related]

  • 2. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
    Ki EY, Park JS, Lee A, Kim TJ, Jin HT, Seo YB, Gen Y, Park MY, Lee SJ.
    Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
    [Abstract] [Full Text] [Related]

  • 3. Immunochemical analysis of human papillomavirus L1 capsid protein in liquid-based cytology samples from cervical lesions.
    Xiao W, Bian M, Ma L, Liu J, Chen Y, Yang B, Wu Q.
    Acta Cytol; 2010; 54(5):661-7. PubMed ID: 20968152
    [Abstract] [Full Text] [Related]

  • 4. [Clinical significance of HPV L1 capsid protein detection in cervical exfoliated cells in high-risk HPV positive women].
    Wang J, Tian Q, Zhang S, Lyu L, Dong J, Lyu W.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):253-7. PubMed ID: 26080935
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human papillomavirus DNA, HPV L1 capsid protein and p16INK4a protein as markers to predict cervical lesion progression.
    Hu H, Zhao J, Yu W, Zhao J, Wang Z, Jin L, Yu Y, Han L, Wang L, Zhu H, Li F.
    Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
    [Abstract] [Full Text] [Related]

  • 7. Correlation between immunocytochemistry of human papilloma virus L1 capsid protein and behavior of low-grade cervical cytology in Korean women.
    Lee SJ, Lee AW, Kim TJ, Kim JH, Bae JH, Lee CW, Song MJ, Yoon JH, Hur SY, Park JS.
    J Obstet Gynaecol Res; 2011 Sep; 37(9):1222-8. PubMed ID: 21518134
    [Abstract] [Full Text] [Related]

  • 8. HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions.
    Mehlhorn G, Hautmann SK, Koch MC, Strehl JD, Hartmann A, Hilfrich R, Beckmann MW, Griesser H.
    Anticancer Res; 2014 Sep; 34(9):5127-32. PubMed ID: 25202103
    [Abstract] [Full Text] [Related]

  • 9. [Detection of human papillomavirus L1 capsid protein expression in liquid-based cytology samples with abnormal cytology.].
    Xiao W, Bian ML, Ma L, Liu J, Chen Y.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):887-91. PubMed ID: 20193413
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
    Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE.
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1675-81. PubMed ID: 20615885
    [Abstract] [Full Text] [Related]

  • 13. [Semi-quantitative detection of HPV L1 capsid protein in exfoliative cytological examination facilitates the differential diagnosis of cervical lesions].
    Xu X, Yang J, Lin N, Yang G.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Nov; 30(11):1194-7. PubMed ID: 25374086
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management.
    Yemelyanova A, Gravitt PE, Ronnett BM, Rositch AF, Ogurtsova A, Seidman J, Roden RB.
    Mod Pathol; 2013 Feb; 26(2):268-74. PubMed ID: 22996373
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.
    Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, Clifford GM.
    Int J Cancer; 2012 Nov 15; 131(10):2349-59. PubMed ID: 22323075
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Does the 'equal management of equal risks' model cause overtreatment in patients with positive cervical cytology results for ASCUS/non-HPV16/18 oncogenic types?
    Karaca İ, Öztürk M, Comba C, Demirayak G, Erdoğan ŞV, Hoşgören M, Özdemir İA.
    Diagn Cytopathol; 2019 Feb 15; 47(2):105-109. PubMed ID: 30444320
    [Abstract] [Full Text] [Related]

  • 20. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
    Hosaka M, Fujita H, Hanley SJ, Sasaki T, Shirakawa Y, Abiko M, Kudo M, Kaneuchi M, Watari H, Kikuchi K, Sakuragi N.
    Int J Cancer; 2013 Jan 15; 132(2):327-34. PubMed ID: 22729477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.